{"transactions":[{"id":743342,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:46:13.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":5853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":5853,"derivative":{"exercise_price":28.78,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":5853},"source":{"system":"sec-edgar","filing":"0001628280-26-042277","document":"wk-form4_1781124370.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828026042277/wk-form4_1781124370.xml","form_type":"4"}},{"id":743341,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:46:13.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":3315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year\nanniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":38467,"source":{"system":"sec-edgar","filing":"0001628280-26-042277","document":"wk-form4_1781124370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828026042277/wk-form4_1781124370.xml","form_type":"4"}},{"id":853746,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":1300,"price":25.4173,"value":33042.49,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.40 to $25.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":426262,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":853745,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":53818,"price":24.9052,"value":1340348.0536,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.40 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":424962,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":853744,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":43581,"price":24.0816,"value":1049500.2096,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.40 to $24.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":371144,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":853743,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":53763,"price":24.1019,"value":1295790.4497,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.79 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":327563,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":853742,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":106554,"price":23.3282,"value":2485713.0228,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.785 to $23.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":273800,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":853741,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":24748,"price":26.4073,"value":653527.8604,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.10 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":167246,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":853740,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-09T23:19:42.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":142498,"price":25.4391,"value":3625020.8718,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.0645 to $26.0213, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein."}],"balance_after":142498,"source":{"system":"sec-edgar","filing":"0000905148-26-001209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514826001209/form4.xml","form_type":"4"}},{"id":1065459,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-15T20:53:14.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":26749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is a cash exercise by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.33,"expiration_date":"2025-09-17","underlying":"Common Stock","underlying_shares":26749},"source":{"system":"sec-edgar","filing":"0001628280-25-040568","document":"wk-form4_1755291190.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025040568/wk-form4_1755291190.xml","form_type":"4"}},{"id":1065458,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:53:14.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":26749,"price":1.33,"value":35576.17,"ownership":{"direct":true},"balance_after":35152,"source":{"system":"sec-edgar","filing":"0001628280-25-040568","document":"wk-form4_1755291190.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025040568/wk-form4_1755291190.xml","form_type":"4"}},{"id":1113700,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-10","kind":"grant","planned":true,"acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The Stock Option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":2771,"derivative":{"exercise_price":64.23,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113699,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-12","kind":"sale","planned":true,"acquired":false,"shares":5049,"price":62.3277,"value":314692.5573,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.89 to $62.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":14363,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113698,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-12","kind":"sale","planned":true,"acquired":false,"shares":19951,"price":61.2783,"value":1222563.3633,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.89 to $61.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":19412,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113697,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":5717,"price":64.2727,"value":367447.0259,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.08 to $64.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":39363,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113696,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":11495,"price":63.4713,"value":729602.5935,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.08 to $64.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":45080,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113695,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":7788,"price":62.5932,"value":487475.8416,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.08 to $63.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":56575,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113694,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-10","kind":"grant","planned":true,"acquired":true,"shares":1538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":8403,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113693,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":1726,"price":64.6728,"value":111625.2528,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.56 to $64.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":64363,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113692,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":18412,"price":64.0171,"value":1178682.8452,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.56 to $64.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":66089,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1113691,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T23:28:32.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":4862,"price":63.2256,"value":307402.8672,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on Novemer 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.56 to $63.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":84501,"source":{"system":"sec-edgar","filing":"0001628280-25-031117","document":"wk-form4_1749770906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025031117/wk-form4_1749770906.xml","form_type":"4"}},{"id":1121549,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":100,"price":66.73,"value":6673.0,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."}],"balance_after":89363,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121548,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":65.9405,"value":263762.0,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.69 to $66.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":89463,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121547,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":12548,"price":65.0942,"value":816802.0216,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.68 to $65.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":93463,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121546,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":5946,"price":64.1928,"value":381690.3888,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.67 to $64.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":106011,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121545,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":1706,"price":63.0749,"value":107605.7794,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.65 to $63.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":111957,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121544,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":700,"price":61.8529,"value":43297.03,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.60 to $62.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":113663,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121543,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-04","kind":"sale","planned":true,"acquired":false,"shares":8600,"price":61.4014,"value":528052.04,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":114363,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121542,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-04","kind":"sale","planned":true,"acquired":false,"shares":16400,"price":60.8234,"value":997503.76,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":122963,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121541,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":1518,"price":61.8287,"value":93855.9666,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.74 to $61.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":139363,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121540,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":11602,"price":61.216,"value":710228.032,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.74 to $61.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":140881,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121539,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":9880,"price":60.2322,"value":595094.136,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.74 to $60.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":152483,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121538,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":59.1445,"value":65058.95,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.73 to $59.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":162363,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1121537,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T00:05:17.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":900,"price":58.0421,"value":52237.89,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.65 to $58.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":163463,"source":{"system":"sec-edgar","filing":"0001628280-25-029800","document":"wk-form4_1749168189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828025029800/wk-form4_1749168189.xml","form_type":"4"}},{"id":1373049,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":500,"price":97.54,"value":48770.0,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."}],"balance_after":164363,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373048,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":10236,"price":96.0339,"value":983003.0004,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.78 to $96.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":164863,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373047,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":16272,"price":95.3282,"value":1551180.4704,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.78 to $95.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":175099,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373046,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":6992,"price":94.4229,"value":660204.9168,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.75 to $94.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":191371,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373045,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":3769,"price":98.2909,"value":370458.4021,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.09 to $98.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":198363,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373044,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":17150,"price":97.593,"value":1673719.95,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.07 to $98.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":202132,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373043,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":2678,"price":96.5713,"value":258617.9414,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.07 to $97.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":219282,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373042,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-06","kind":"sale","planned":true,"acquired":false,"shares":9403,"price":95.6767,"value":899648.0101,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.07 to $96.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":221960,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373041,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":2191,"price":98.4295,"value":215659.0345,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.94 to $98.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":231363,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373040,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":11487,"price":97.1687,"value":1116176.8569,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.91 to $97.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":233554,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373039,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":11756,"price":96.4897,"value":1134332.9132,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.91 to $96.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":245041,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373038,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":7566,"price":95.3828,"value":721666.2648,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.64 to $95.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes shares previously held indirectly through Mallard Fund, L.P., which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes shares previously held indirectly through Kestrel Fund, L.P., which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by The 2:22 DNA Trust except to the extent of any pecuniary interest therein."}],"balance_after":256797,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373037,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"other","planned":true,"acquired":false,"shares":62944,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Kestrel Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On November 5, 2024, Kestrel Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 3,316 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"On November 5, 2024, Kestrel Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 3,316 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373036,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"other","planned":true,"acquired":false,"shares":172016,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Mallard Fund, L.P"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 5, 2024, Mallard Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 8,511 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On November 5, 2024, Mallard Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 8,511 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1373035,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T01:05:46.000Z","date":"2024-11-05","kind":"other","planned":true,"acquired":false,"shares":660302,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 5, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 51,245 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 5, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 51,245 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-24-046469","document":"wk-form4_1731027936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024046469/wk-form4_1731027936.xml","form_type":"4"}},{"id":1408807,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":28689,"price":80.6477,"value":2313701.8653,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.33 to $81.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":197453,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408806,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":9402,"price":79.7805,"value":750096.261,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.33 to $80.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":226142,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408805,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":2318,"price":78.8939,"value":182876.0602,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.33 to $79.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":235544,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408804,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-12","kind":"sale","planned":true,"acquired":false,"shares":4458,"price":77.9953,"value":347703.0474,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.27 to $78.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":237862,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408803,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":4182,"price":78.6718,"value":329005.4676,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.48 to $79.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":242320,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408802,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":20732,"price":78.1207,"value":1619598.3524,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.48 to $78.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":246502,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408801,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":4880,"price":77.0896,"value":376197.248,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.46 to $77.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":267234,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408800,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":8904,"price":75.9037,"value":675846.5448,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.435 to $76.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":272114,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408799,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":17810,"price":76.5984,"value":1364217.504,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.24 to $76.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":281018,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1408798,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-13T00:03:02.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":18690,"price":75.7813,"value":1416352.497,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.24 to $76.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":298828,"source":{"system":"sec-edgar","filing":"0001628280-24-040284","document":"wk-form4_1726185775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024040284/wk-form4_1726185775.xml","form_type":"4"}},{"id":1414162,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":900,"price":76.9578,"value":69262.02,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.79 to $77.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":317518,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414161,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":12405,"price":76.3259,"value":946822.7895,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.78 to $76.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":318418,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414160,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":400,"price":76.3675,"value":30547.0,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.24 to $76.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":330823,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414159,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":23164,"price":75.6886,"value":1753250.7304,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.23 to $76.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":331223,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414158,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":12648,"price":74.8991,"value":947323.8168,"ownership":{"direct":false,"nature":"By The 2:22 DNA Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.23 to $75.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":354387,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414157,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":200,"price":76.405,"value":15281.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.33 to $76.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":6543,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414156,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":10998,"price":75.697,"value":832515.606,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.25 to $76.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":6743,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414155,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":6222,"price":74.9083,"value":466079.4426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.25 to $75.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":17741,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414154,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":78.91,"value":7891.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."}],"balance_after":23963,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414153,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":77.999,"value":77999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.90 to $78.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":24063,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414152,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":3629,"price":77.2273,"value":280257.8717,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.85 to $77.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":25063,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414151,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":19725,"price":76.3178,"value":1505368.605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.85 to $76.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":28692,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1414150,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T23:13:54.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":10766,"price":75.1713,"value":809294.2158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.85 to $75.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":48417,"source":{"system":"sec-edgar","filing":"0001628280-24-039573","document":"wk-form4_1725578026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024039573/wk-form4_1725578026.xml","form_type":"4"}},{"id":1488599,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:33:41.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":2526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option was granted on June 4, 2024 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":2526,"derivative":{"exercise_price":67.29,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":2526},"source":{"system":"sec-edgar","filing":"0001628280-24-027068","document":"wk-form4_1717706010.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024027068/wk-form4_1717706010.xml","form_type":"4"}},{"id":1488598,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:33:41.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":59183,"source":{"system":"sec-edgar","filing":"0001628280-24-027068","document":"wk-form4_1717706010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000162828024027068/wk-form4_1717706010.xml","form_type":"4"}},{"id":1505740,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-23T01:31:59.000Z","date":"2024-05-20","kind":"other","planned":false,"acquired":false,"shares":164063,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Mallard Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 20, 2024, Mallard Fund, L.P. distributed shares on a pro rata basis, for no consideration, including 37 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On May 20, 2024, Mallard Fund, L.P. distributed shares on a pro rata basis, for no consideration, including 37 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein."}],"balance_after":180527,"source":{"system":"sec-edgar","filing":"0000905148-24-001579","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514824001579/form4.xml","form_type":"4"}},{"id":1505739,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-23T01:31:59.000Z","date":"2024-05-20","kind":"other","planned":false,"acquired":false,"shares":1949104,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 20, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 163,030 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 20, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 163,030 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein."}],"balance_after":711547,"source":{"system":"sec-edgar","filing":"0000905148-24-001579","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514824001579/form4.xml","form_type":"4"}},{"id":1524929,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-08T01:45:55.000Z","date":"2024-05-03","kind":"other","planned":false,"acquired":false,"shares":1785127,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By White Tailed Ptarmigan, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 3, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 421,061 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 3, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 421,061 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the \"CPMG Funds\"). Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Kent McGaughy, Jr., CPMG, Inc. and White Tailed Ptarmigan, LP jointly report their beneficial ownership of these shares on a separate Form 4."}],"balance_after":2823681,"source":{"system":"sec-edgar","filing":"0000905148-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514824001299/form4.xml","form_type":"4"}},{"id":1772227,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":993929,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":993929},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772226,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":114946,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":114946},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772225,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1490,"ownership":{"direct":false,"nature":"By Redbird Life Sciences Partners, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772224,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":123279,"ownership":{"direct":false,"nature":"By CD Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":123279},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772223,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":307776,"ownership":{"direct":false,"nature":"By Kestrel Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":307776},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772222,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150186,"ownership":{"direct":false,"nature":"By Mallard Fund, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":150186},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772221,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class B common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1251,"ownership":{"direct":false,"nature":"By CPMG, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":1251},"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772220,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":134,"ownership":{"direct":false,"nature":"By Redbird Life Sciences Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772219,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11076,"ownership":{"direct":false,"nature":"By CD Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772218,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":160265,"ownership":{"direct":false,"nature":"By Kestrel Fund, LP("},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772217,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":334740,"ownership":{"direct":false,"nature":"By Sandpiper Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772216,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37909,"ownership":{"direct":false,"nature":"By Crested Crane, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772215,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":109415,"ownership":{"direct":false,"nature":"By Mallard Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772214,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":431155,"ownership":{"direct":false,"nature":"By Yellow Warbler, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772213,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":748253,"ownership":{"direct":false,"nature":"By Roadrunner Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772212,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":442560,"ownership":{"direct":false,"nature":"By Gallopavo, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772211,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34897,"ownership":{"direct":false,"nature":"By Managed Account for Trustees of the University of Pennsylvania"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772210,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44200,"ownership":{"direct":false,"nature":"By Barred Owl Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772209,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5464,"ownership":{"direct":false,"nature":"By Elepaio Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772208,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":137962,"ownership":{"direct":false,"nature":"By Killdeer Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772207,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":282246,"ownership":{"direct":false,"nature":"By Willet Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772206,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":116512,"ownership":{"direct":false,"nature":"By Nighthawk Partners, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}},{"id":1772205,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":39711,"kind":"person","name":"Desai Antal Rohit","position":1,"cik":"0001881616","reported_name":"Desai Antal Rohit","relationship":{"director":true,"ten_percent_owner":true}},{"id":91372,"kind":"organization","name":"CPMG Inc","position":2,"cik":"0001372218","reported_name":"CPMG Inc","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2023-09-28T20:32:06.000Z","date":"2023-09-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":113,"ownership":{"direct":false,"nature":"By CPMG, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. (\"Biogen\") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the \"Effective Time\"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the \"Funds\"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of CPMG, Inc. and Mr. Desai (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-23-001027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1881616/000090514823001027/form4.xml","form_type":"4"}}],"next_cursor":"2023-09-28T20:32:06.000000Z,1772205"}